INTRODUCTION
============

Spontaneous intracerebral hemorrhage (ICH) usually results from the rupture of small arteries in the brain and represents 10--30% of all strokes[@b20-jkns-60-5-511]. ICH is associated with high rate of mortality and long-term disability in survivors. ICH and ischemic stroke share common vascular risk factors such as aging and hypertension. Secondary prevention of recurrence is the main treatment goal after prior stroke for both ischemic and hemorrhagic stroke. Importantly, several studies reported no differences of frequency of hemorrhagic or ischemic stroke recurrence after prior ICH[@b7-jkns-60-5-511],[@b8-jkns-60-5-511],[@b26-jkns-60-5-511]. However, risk factors and features of recurrent stroke after ICH are not firmly established. Extracranial carotid stenosis is a well-known risk factor for stroke. Furthermore, it is widely accepted that intracranial cerebral arterial stenosis (ICAS) is more prevalent in Asians than in Caucasian stroke population, and 30--50% of stroke in Asians is suggested to be caused by ICAS[@b3-jkns-60-5-511],[@b25-jkns-60-5-511]. Therefore, detection of cerebral arterial stenosis, such as ICAS and extracranial cerebral arterial stenosis (ECAS) may have clinical significance for secondary stroke prevention in ICH patients. Although a previous study suggested that ICAS or ECAS occur in one-fifth of patients with ICH[@b22-jkns-60-5-511], little is known of the prevalence and factors associated with cerebral arterial stenosis in patients with ICH.

We investigated the prevalence of ICAS and ECAS, and analyzed the factors predicting the presence of arterial stenosis in patients presenting with spontaneous ICH.

MATERIALS AND METHODS
=====================

Patients
--------

Patients with spontaneous ICH who were admitted to a tertiary university hospital were included. Patients were retrospectively identified from the neurosurgical database for ICH between January 2009 to December 2012. The inclusion criteria were as follows: 1) spontaneous ICH within 24 hours of presumed symptom onset, 2) patients underwent computed tomography angiography (CTA), and 3) age \>18 years. The exclusion criteria were ICH due to secondary causes like arteriovenous malformation, Moyamoya disease, traumatic ICH, aneurysm, neoplasm, and hemorrhagic conversion of cerebral infarction. The local institutional review board approved this retrospective study and waived the need for informed consent.

CTA and cerebral arterial stenosis
----------------------------------

CTA was used to analyze the presence of intracranial and extracranial stenosis. All patients underwent multi-detector CTA, which was performed using a Brilliance 40-channel CT v2.2 (Philips Medical System, Best, The Netherlands) with the following parameters: 120 kVp, 300 mA, 0.8 mm slice thickness, 0.3 mm slice acquisition interval, a pitch of 0.67, and intravenous administration of 150 mL of iodinated contrast media (Omnipasque 300) at a rate of 4.0--4.5 mL/s under the control of an auto-injection protocol. Imaging data were transferred to two computer workstations (Extended Brilliance Workspace v3.0 and Rapidia v2.8) for post-processing.

Stenosis was determined as the ratio of the diameter at the segment of most severe stenosis divided by the diameter of a proximal or nearby normal segment[@b21-jkns-60-5-511]. More than 50% stenosis was defined as arterial stenosis. We analyzed stenosis for intracranial artery and extracranial artery. Intracranial arteries that were evaluated were the intracranial segment of internal carotid artery, basilar artery, anterior cerebral artery, middle cerebral artery, and posterior cerebral artery. Extracranial stenosis was analyzed in the extracranial portion of the internal carotid artery. We excluded the extracranial and intracranial vertebral arteries from this analysis since the hypoplastic vertebral arteries are frequently found in normal subjects, which make it difficult to differentiate between non-specific hypoplasia and atherosclerotic stenosis. Location of ICH were categorized as lobar (cortical and subcortical), ganglionic (putamen and thalamus), and infratentorial (brainstem and cerebellum).

Clinical characteristics
------------------------

The Glasgow coma scale was recorded to assess the initial neurological status on admission, and patient's functional outcome at discharge and 90 days were assessed using the Glasgow outcome scale (1 to 5, good recovery to death). Hypertension was defined as a self-reported use of blood pressure-lowering medication or history of hypertension or blood pressure \>160/100 mmHg at least 1 week after stroke onset. Diabetes mellitus was defined present if patient was taking hypoglycemic medication or had a random glucose level ≥200 mg/dL. Dyslipidemia was defined when using anti-lipidemic agent or total cholesterol level ≥220 mg/dL or low-density lipoprotein cholesterol level ≥160 mg/dL. Current cigarette smoking was considered a positive smoking habitus. The estimated glomerular filtration rate (eGFR) was calculated using the equation proposed by the MDRD study group[@b13-jkns-60-5-511].

Statistical analysis
--------------------

Baseline characteristics and location of ICH were compared between patients with ICAS and without ICAS. We also compared patients with cerebral arterial stenosis (defined as presence of ICAS and/or ECAS) and those without cerebral arterial stenosis. Baseline characteristics and location of ICH were compared using chi-square test and the Student t-test, as appropriate. Multivariable analyses were performed via multiple logistic regression to determine the factors associated with presence of ICAS and cerebral arterial stenosis. In multivariable analysis, variables with *p*\<0.2 from the univariate analysis and biologically plausible variables were selected as potential factors for statistical analysis. All analyses were performed using PASW statistics version 18.0 (IBM Corp., Armonk, NY, USA).

RESULTS
=======

Present study included 187 patients with spontaneous ICH. Of them, 20 patients who did not undergo CTA were excluded from this analysis. The main reason for not performing CTA was irritability and/or unstable patient condition due to acute stroke. Therefore, 167 patients were finally included. Mean age was 61.3±13.6 years. Sixty five (38.9%) were female, 59.3% had hypertension, 16.8% had diabetes, 19.2% had dyslipidemia, and 23.4% were current smoker ([Table 1](#t1-jkns-60-5-511){ref-type="table"}).

Among the 167 patients who underwent CTA, 32 (19.2%) had at least one ICAS, and 15 (9%) had multiple ICAS ([Table 2](#t2-jkns-60-5-511){ref-type="table"}). Extracranial carotid stenosis was detected in 12 (7.2%) patients, and 39 (23.4%) patients had cerebral arterial stenosis (ICAS and/or ECAS). Patients with ICAS were older, more frequently had diabetes, and had a higher initial serum glucose level than those without ICAS. Hemoglobin level was lower in patients with ICAS ([Table 3](#t3-jkns-60-5-511){ref-type="table"}). However, other vascular risk factors and laboratory finding did not differ between the two groups. Location of hemorrhage (lobar, ganglionic, and infratentorial) and volume of ICH also did not differ between the patients with and without ICAS. Patients with cerebral arterial stenosis (ICAS and/or ECAS) were older, had diabetes and lower hemoglobin level, which is consistent with the findings of patients with ICAS. However, patients with cerebral arterial stenosis had higher prevalence of hypertension and decreased kidney function estimated by eGFR compared to those without cerebral arterial stenosis ([Table 4](#t4-jkns-60-5-511){ref-type="table"}).

Multivariable logistic regression analyses showed that aging and presence of diabetes independently predicted the presence of ICAS. However, other factors including hypertension and dyslipidemia were not associated with the presence of ICAS ([Table 5](#t5-jkns-60-5-511){ref-type="table"}). Factors independently predicting the presence of cerebral arterial stenosis using multivariable logistic regression analysis were aging, diabetes, and hypertension Multivariable logistic regression analysis for ECAS was not done since the sample size of patients with ECAS (n=12) was not enough to demonstrate the effect in multivariable modeling.

DISCUSSION
==========

Present study shows that 19.2% of patients with spontaneous ICH had ICAS. Multivariable analysis identified aging and diabetes as independent factors associated with the presence of ICAS. Compared with ICAS, extracranial carotid stenosis was less frequently found (7.2%). Any presence of cerebral arterial stenosis (presence of ICAS and/or ECAS) was observed in 23.4% of the patients. Aging, hypertension, and diabetes were factors for the presence of cerebral atherosclerosis.

Evidence of cerebral atherosclerosis in patients with spontaneous ICH has been sparsely investigated until recently. A Japanese study reported that 13% of patients had ICAS and 9% had ECAS (combining extracranial carotid artery and extracranial vertebral artery)[@b22-jkns-60-5-511]. However, the prevalence of cerebral atherosclerosis in patients with ICH has not been reported in the western population. It is well known that ICAS is more prevalent in Asians than in Caucasian stroke population[@b3-jkns-60-5-511], and reportedly causes up to 30--50% of ischemic strokes in Asians[@b25-jkns-60-5-511]. Several studies investigated the prevalence of asymptomatic ICAS in patients presenting with ischemic stroke in another vascular territory. Coexisting asymptomatic ICAS was highly prevalent (27%) in patients with ischemic stroke enrolled in the WASID trial[@b18-jkns-60-5-511]. ICAS was reported in 10% and was symptomatic in 7% of Norwegian ischemic stroke/TIA population[@b15-jkns-60-5-511]. However, the prevalence of asymptomatic ICAS in subjects without stroke is not well established. Transcranial Doppler study in subjects with vascular risk factors showed that 12% had ICAS with increasing prevalence that correlated with the increasing number of vascular risk factors[@b24-jkns-60-5-511]. A prevalence study of ICAS in a non-stroke population showed that aging was associated with ICAS, reflecting the strong relationship between aging and atherosclerotic burden. Although we do not know the real prevalence of ICAS in different population groups (ischemic stroke, ICH, and non-stroke), the prevalence of ICAS in patients with ICH as shown in our study is comparable to previously-reported prevalence of asymptomatic ICAS in those with ischemic stroke.

The risk of recurrent stroke in patients with symptomatic ICAS is among the highest of the stroke subtypes[@b11-jkns-60-5-511]. A recent randomized controlled trial in patients with ICAS reported a risk of any recurrent stroke or death of 17.5% at 1 year and 19.8% at 2 years despite best medical management[@b6-jkns-60-5-511]. However, despite the high risk of subsequent vascular events in patients with symptomatic ICAS, the significance of asymptomatic ICAS remains unknown. The risk of stroke from asymptomatic stenosis is thought to be relatively low[@b18-jkns-60-5-511], however, other study showed asymptomatic ICAS is significant risk factor for future stroke[@b16-jkns-60-5-511]. Furthermore, presence of asymptomatic ICAS may portend advanced atherosclerosis and could be a risk marker for subsequent vascular event as suggested by high prevalence of coronary artery disease in patients with symptomatic ICAS[@b1-jkns-60-5-511],[@b17-jkns-60-5-511]. It is, therefore, possible that the presence of asymptomatic ICAS in patients with ICH may suggest higher risk of ischemic vascular event despite incident hemorrhagic stroke.

ICH and ischemic stroke share common vascular risk factors such as aging and hypertension. Recurrent stroke after prior ICH could present as either hemorrhagic or ischemic subtypes, although the epidemiology and features of recurrent stroke after ICH are unclear. Recurrent ICH has been reported to occur more frequently than ischemic stroke after prior ICH[@b2-jkns-60-5-511],[@b9-jkns-60-5-511]. However, other studies claimed that there are no differences of recurrence between hemorrhagic and ischemic stroke or numerically higher rate of recurrent ischemic stroke after prior ICH[@b7-jkns-60-5-511],[@b8-jkns-60-5-511],[@b26-jkns-60-5-511]. Which clinical characteristics represent higher risk for ischemic stroke among ICH population is still unknown. Therefore, secondary stroke prevention strategy for reducing ischemic stroke event in patients with prior hemorrhagic stroke has not been established. Our study showed that ICH patients with older age and diabetes have higher risk for ICAS, and those with diabetes and hypertension are at higher risk for cerebral atherosclerosis, which might have a clinical implication for preventing subsequent ischemic event in patients with prior ICH.

Lobar and non-lobar ICH are presumably caused by different types of microangiopathy, and risk factors for ICH may vary according to the location of ICH[@b12-jkns-60-5-511]. Regarding the location of ICH, lobar ICH frequently recurs as lobar ICH suggesting the participation of cerebral amyloid angiopathy as a main pathogenesis, but ganglionic ICH may have a chance of recurrence both as infarction and ganglionic ICH, suggesting the participation of intracranial atherosclerosis[@b7-jkns-60-5-511],[@b14-jkns-60-5-511],[@b19-jkns-60-5-511]. However, the presence of cerebral arterial stenosis did not differ between patients with lobar and non-lobar ICH in the present study, and further larger sample size study is required to elucidate the association between cerebral arterial stenosis and location of ICH.

ICAS is more prevalent in Asian, and black people than in Caucasians. As well, small vessel disease such as hypertensive ICH and lacunar infarcts are more prevalent in Asians. In keeping with this epidemiologic association, patients with lacunar stroke often experience hemorrhagic stroke[@b4-jkns-60-5-511],[@b10-jkns-60-5-511]. The reasons for differing prevalence of ICAS, lacunar infarct, and ICH among populations remain unknown. Hypertension is the most important risk factor for small vessel disease and, it has been suggested that the role of hypertension may be greater in ICAS than in ECAS[@b5-jkns-60-5-511],[@b23-jkns-60-5-511]. Therefore, it can be speculated that hypertensive vascular damage might be the factor linking ICAS and ICH.

There are several limitations to our study. First, this was a retrospective cross-sectional analysis. Therefore, whether the presence of cerebral arterial stenosis implicate poor vascular prognosis or not could not be addressed and remains to be determined by further prospective investigation. Second, because the sample size was relatively small, the association of arterial stenosis and location of ICH was not determined in the present study. Further studies with a larger sample size are required to analyze the relation of ICH pattern and arterial stenosis. Also, because of the relative scarcity of patients with extracranial carotid stenosis, we did not analyze the characteristics of patients with ICH and extracranial carotid stenosis. Third, other causes of arterial stenosis such as vasospasm after ICH could not be excluded because follow-up angiography was not done in most patients. Finally, although we investigated the prevalence of ICAS and ECAS in patients with ICH, prevalence of ICAS and ECAS in non-stroke population was not available in the present study. Therefore, significance of presence of arterial stenosis in ICH population compared to non-stroke population could not be clearly determined in the present study. Further study enrolling subjects with ICH, ischemic stroke, and non-stroke population are required to clarify the association between ICH and cerebral arterial stenosis.

CONCLUSION
==========

This study showed that 19.2% of patients with spontaneous ICH had ICAS, but the prevalence of ECAS was relatively lower (7.2%) compared with ICAS. Aging and diabetes are factors associated with the presence of ICAS, and aging, diabetes, and hypertension are associated with the presence of cerebral arterial stenosis in patients with ICH. Because stroke recurrence could present as either ischemic or hemorrhagic stroke, further studies regarding the predictors of different subtypes of recurrent stroke should be undertaken in patients with ICH.

###### 

Baseline characteristics

                              Value (n=167)
  --------------------------- ---------------
  Female sex                  65 (38.9)
  Age (years)                 61.3±13.6
  Hypertension                99 (59.3)
  Diabetes                    28 (16.8)
  Dyslipidemia                32 (19.2)
  Previous stroke             29 (17.4)
  Current smoking             39 (23.4)
  Initial GCS                 12.6±3.3
  Discharge GOS               3.3±0.7
  3 months GOS                3.4±0.9
  Leukocyte (mm^3^)           9244±3874
  Hemoglobin (g/dL)           14.1±1.8
  Serum glucose (mg/dL)       148.1±53.1
  Total cholesterol (mg/dL)   182.5±44.4
  HDL cholesterol (mg/dL)     55.0±18.6
  LDL cholesterol (mg/dL)     111.5±40.7
  Triglyceride (mg/dL)        105.8±81.2
  Serum creatinine (mg/dL)    0.93±0.48
  eGFR (mL/min/1.73m^2^)      89.7±28.5

Values are presented as mean±standard deviation or number (%). GCS: Glasgow coma scale, GOS: Glasgow outcome scale, HDL: high-density lipoprotein, LDL: low-density lipoprotein, eGFR: estimated glomerular filtration rate

###### 

Radiological features

                               Value (n=167)
  ---------------------------- ---------------
  Location of ICH              
   Ganglionic                  118 (70.6)
   Lobar                       28 (16.8)
   Brainstem/cerebellum        21 (12.6)
                               
  Intracranial stenosis        32 (19.2)
   Middle cerebral artery      19 (11.4)
   Posterior cerebral artery   2 (1.2)
   Internal carotid artery     12 (7.2)
   Basilar artery              6 (3.6)
   Multiple stenosis           15 (9)
                               
  Extracranial stenosis        12 (7.2)

Values are presented as number (%). ICH: intracerebral hemorrhage

###### 

Comparison between patients with intracranial stenosis and those without stenosis

                              With stenosis (n=32)   Without stenosis (n=135)   *p*-value
  --------------------------- ---------------------- -------------------------- -----------
  Age (years)                 67.6±11.8              58.9±13.6                  0.004
                                                                                
  Female sex                  14 (43.8)              51 (37.8)                  0.533
                                                                                
  Hypertension                24 (75)                75 (56.8)                  0.059
                                                                                
  Diabetes                    11 (34.4)              17 (12.9)                  0.004
                                                                                
  Dyslipidemia                7 (21.9)               25 (18.9)                  0.707
                                                                                
  Previous stroke             6 (18.8)               23 (17.4)                  0.86
                                                                                
  Current smoking             6 (18.8)               33 (25)                    0.456
                                                                                
  Initial GCS                 12.4±3.6               12.6±3.2                   0.83
                                                                                
  Discharge GOS               3.1±0.9                3.4±0.7                    0.062
                                                                                
  3 months GOS                3.1±1.1                3.5±0.8                    0.014
                                                                                
  Initial SBP (mmHg)          183±35                 174±38                     0.273
                                                                                
  Leukocyte (mm^3^)           8887±5248              9329±3486                  0.653
                                                                                
  Hemoglobin (g/dL)           13.5±1.9               14.2±1.8                   0.033
                                                                                
  Serum glucose (mg/dL)       168±52                 143±52                     0.017
                                                                                
  Total cholesterol (mg/dL)   177±44                 183±45                     0.459
                                                                                
  HDL cholesterol (mg/dL)     52±13.6                55.7±19.6                  0.327
                                                                                
  LDL cholesterol (mg/dL)     110.8±39.5             111.7±41.1                 0.912
                                                                                
  Triglyceride (mg/dL)        92.5±76.8              108.9±82.2                 0.327
                                                                                
  Serum creatinine (mg/dL)    1.2±0.9                0.9±.02                    0.102
                                                                                
  eGFR (mL/min/1.73m^2^)      81.8±36.7              91.5±25.9                  0.082
                                                                                
  Location of ICH                                                               0.981
   Ganglionic                 23                     95                         
   Lobar                      5                      23                         
   Brainstem/Cerebellum       4                      17                         

Values are presented as mean±standard deviation or number (%). GCS: Glasgow coma scale, GOS: Glasgow outcome scale, SBP: systolic blood pressure, HDL: high-density lipoprotein, LDL: low-density lipoprotein, eGFR: estimated glomerular filtration rate

###### 

Comparison between patients with cerebral arterial stenosis (presence of intracranial and/or extracranial stenosis) and those without cerebral arterial stenosis

                              With stenosis (n=39)   Without stenosis (n=128)   *p*-value
  --------------------------- ---------------------- -------------------------- -----------
  Age (years)                 67.9±11.6              59.3±13.5                  \<0.001
                                                                                
  Female sex                  15 (38.5)              50 (39.1)                  0.946
                                                                                
  Hypertension                29 (74.4)              70 (54.7)                  0.041
                                                                                
  Diabetes                    13 (33.3)              15 (12)                    0.002
                                                                                
  Dyslipidemia                9 (23.1)               23 (18)                    0.52
                                                                                
  Previous stroke             8 (20.5)               21 (16.4)                  0.596
                                                                                
  Smoking current             9 (23.1)               30 (23.4)                  0.906
                                                                                
  Initial GCS                 12.5±3.4               12.6±3.2                   0.982
                                                                                
  Discharge GOS               3.2±0.8                3.4±0.7                    0.13
                                                                                
  3month GOS                  3.2±0.9                3.5±0.8                    0.039
                                                                                
  Initial SBP (mmHg)          182±36                 174±38                     0.26
                                                                                
  Leukocyte (mm^3^)           8980±5077              9326±3442                  0.692
                                                                                
  Hemoglobin (g/dL)           13.6±1.8               14.2±1.8                   0.046
                                                                                
  Serum glucose (mg/dL)       164±54                 143±52                     0.034
                                                                                
  Total cholesterol (mg/dL)   181±48                 183±43                     0.794
                                                                                
  HDL cholesterol (mg/dL)     54.8±15.6              55.0±19.4                  0.946
                                                                                
  LDL cholesterol (mg/dL)     112.2±45.2             111.3±39.4                 0.913
                                                                                
  Triglyceride (mg/dL)        90.7±75.1              110.4±82.7                 0.21
                                                                                
  Serum creatinine (mg/dL)    1.1±0.9                0.9±0.2                    0.057
                                                                                
  eGFR (mL/min/1.73m^2^)      80.2±33.7              92.6±26.1                  0.018
                                                                                
  Location of ICH                                                               0.511
   Ganglionic                 26                     92                         
   Lobar                      6                      22                         
   Brainstem/Cerebellum       7                      14                         

Values are presented as mean±standard deviation or number (%). GCS: Glasgow coma scale, GOS: Glasgow outcome scale, SBP: systolic blood pressure, HDL: high-density lipoprotein, LDL: low-density lipoprotein, eGFR: estimated glomerular filtration rate, ICH: intracerebral hemorrhage

###### 

Multivariable logistic regression analysis for presence of intracranial stenosis and cerebral arterial stenosis (presence of intracranial and/or extracranial stenosis)

                               OR     95% CI        *p*-value
  ---------------------------- ------ ------------- -----------
  Intracranial stenosis                             
   Age (per 1 year)            1.05   1.01--1.09    0.015
   Female sex                  0.79   0.29--2.17    0.647
   Hypertension                2.49   0.88--7.01    0.085
   Diabetes                    3.09   1.12--8.56    0.03
   Dyslipidemia                1.32   0.46--3.81    0.607
   Prior stroke                0.53   0.16--1.71    0.285
   Smoking                     1.66   0.51--5.42    0.4
   Hemoglobin                  0.89   0.68--1.16    0.38
   eGFR                        0.99   0.98--1.01    0.689
                                                    
  Cerebral arterial stenosis                        
   Age (per 1 year)            1.07   1.03--1.12    0.001
   Female sex                  0.53   0.20--1.41    0.201
   Hypertension                2.95   1.09--7.95    0.032
   Diabetes                    3.33   1.21--9.16    0.02
   Dyslipidemia                1.66   0.61--4.56    0.323
   Prior stroke                0.57   0.18--1.74    0.322
   Smoking                     2.53   0.84--−7.62   0.099
   Hemoglobin                  0.9    0.69--1.18    0.445
   eGFR                        0.99   0.98--1.01    0.345

OR: odds ratio, CI: confidence interval, eGFR: estimated glomerular filtration rate
